<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00184899</url>
  </required_header>
  <id_info>
    <org_study_id>Intralipid-Ado</org_study_id>
    <secondary_id>ZonMw Nr. 920-03-249</secondary_id>
    <nct_id>NCT00184899</nct_id>
  </id_info>
  <brief_title>The Potential Role for Adenosine in the Haemodynamic Effects of Free Fatty Acids</brief_title>
  <official_title>The Potential Role for Adenosine in the Haemodynamic Effects of Free Fatty Acids</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZonMw: The Netherlands Organisation for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <brief_summary>
    <textblock>
      The metabolic syndrome is associated with hyperdynamic circulation and sympathetic
      activation. Recently, Bakker et al. (Atherosclerosis 2002) described the hypothesis that free
      fatty acids are responsible for this association. The investigators hypothesize that in
      patients with obesity and the metabolic syndrome, an increased intracellular concentration of
      long-chain fatty acyl (LCFA)-CoA (the intracellular equivalent of free fatty acids) induces
      an increase in adenosine. Adenosine receptor stimulation, in turn, induces vasodilation and
      sympathetic activation.

      The investigators aimed to assess this effect of free fatty acids on the adenosine system in
      healthy volunteers.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date>August 2006</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Educational/Counseling/Training</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Forearm blood flow</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Vasoactive effect of caffeine</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Sympathetic activity (noradrenaline spillover, spectral analysis)</measure>
  </primary_outcome>
  <enrollment>20</enrollment>
  <condition>Obesity</condition>
  <condition>Metabolic Syndrome X</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous infusion of Intralipid/heparin</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous infusion of Glycerol/heparin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers

        Exclusion Criteria:

          -  Pregnancy

          -  Asthma

          -  Use of medication

          -  Cardiovascular/pulmonary disease and diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Smits, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Radboud University Nijmegen Medical Centre</name>
      <address>
        <city>Nijmegen</city>
        <zip>6500HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Bakker SJ, Gans RO, ter Maaten JC, Teerlink T, Westerhoff HV, Heine RJ. The potential role of adenosine in the pathophysiology of the insulin resistance syndrome. Atherosclerosis. 2001 Apr;155(2):283-90.</citation>
    <PMID>11254897</PMID>
  </reference>
  <verification_date>February 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2005</study_first_posted>
  <last_update_submitted>February 28, 2007</last_update_submitted>
  <last_update_submitted_qc>February 28, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 1, 2007</last_update_posted>
  <keyword>free fatty acids</keyword>
  <keyword>vasodilation</keyword>
  <keyword>sympathetic activity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin</mesh_term>
    <mesh_term>Adenosine</mesh_term>
    <mesh_term>Soybean oil, phospholipid emulsion</mesh_term>
    <mesh_term>Glycerol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

